NCT01018563 2021-12-08
An Open Label Extension Study of the Efficacy of MORAb-003
Morphotek
Phase 2 Terminated
Clinical Trials
3 trialsNCT01004380 2014-07-17
Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer
Morphotek
Phase 1 Completed
NCT00428766 2013-11-06
Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer
Morphotek
Phase 1 Completed